Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:

Clinical Cancer Research
Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations

Cancer Biology
Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery

Cancer Prevention
Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach

Bioinformatics
Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers


Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, research methods papers, and brief communications, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.

We aim to be a truly global forum for high-quality cancer research, and we think that the best research should be published and made widely accessible as quickly as possible. 

Editor-in-Chief
Qingyi Wei, MD, PhD
Duke Cancer Institute, Duke University Medical Center,
Durham NC, USA
Conflict of Interest Statement
 
Associate Editors
Cancer Prevention
Paolo Boffetta, MD
Tisch Cancer Institute,
New York NY, USA
Zhibin Hu, MD, PhD
Nanjing Medical University School of Public Health,
China
Matthew B. Schabath, PhD
H. Lee Moffitt Cancer Center and Research Institute,
Tampa FL, USA
Kyle M. Walsh, PhD
Duke University Medical Center,
Durham NC, USA
Clinical Cancer Research
Stefano Arcangeli, MD
University of Milan Bicocca,
Rome, Italy
Dhyan Chandra, PhD
Roswell Park Cancer Institute,
Buffalo NY, USA
Taofeek K. Owonikoko, MD, PhD, MSCR
Emory University School of Medicine,
Atlanta, GA, USA
Surya P. Rednam, MD
Texas Children’s Cancer Center,
Houston TX, USA
Rashmi Kanagal-Shamanna, MD
The University of Texas MD Anderson Cancer Center,
Houston TX, USA
Zhi-Ming Shao, MD
Shanghai Medical School,
Shanghai, China
Cancer Biology
Dipanjan Chanda, PhD
Department of Endocrinology,
Kyungpook National University Hospital,
Daegu, South Korea
Jingxuan Pan, MD, PhD
State Key Laboratory of Ophthalmology, 
Sun Yat-sen University Zhongshan Ophthalmic Center, 
Guangzhou, China
Vasily S. Romanov, PhD
Jena University Hospital (UKJ)
Jena, Germany
Ajay Singh, PhD
Mitchell Cancer Institute,
University of South Alabama,
Mobile AL, USA
Gong Yang, DVM, PhD
Fudan University Shanghai Cancer Center,
The Fifth People's Hospital of Shanghai, Fudan University
Shanghai Medical School, Fudan University
Shanghai, China
Yifeng Zhou, PhD
Department of Genetics, Medical College of Soochow University, 
Suzhou, China
Wenge Zhu, PhD
The George Washington University School of Medicine and Health Science,
Washington DC, USA
Bioinformatics and Biostatistics
Steven A. Eschrich, PhD
Department of Biostatistics & Bioinformatics, 
Moffitt Cancer Center, 
Tampa FL, USA
Jiang Shu, PhD
Department of Computer Science & Engineering, 
University of Nebraska-Lincoln, 
Lincoln NE, USA
Editorial Board Members
Cancer Biology
Richard J. Ablin, University of Arizona College of Medicine, Tucson, USA
Dolores Cahill, University College Dublin, Dublin, Ireland
David W. Chan,The University of Hong Kong, Hong Kong, China
Dhyan Chandra, Roswell Park Cancer Institute, New York, USA
Ming Chen, Department of Pathology, Duke University School of Medicine, Durham, USA
Zhijun Dai, Second Affiliated Hospital of Xi’an Jiaotong University , Xi’an, China
Rosalind Eeles, Institute of Cancer Research, Sutton, UK
Manel Esteller, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain
Kai Fu, Central South University, Hunan, China
Elizabeth A. Grimm, The University of Texas MD Anderson Cancer Center, Houston, USA
Xiaoxiang Guan, Nanjing University School of Medicine, Nanjing , China
Jos Jonkers, Netherlands Cancer Institute, Amsterdam, The Netherlands
Zhiyong Han, The George Washington University, Washington DC, USA
Zhaohui Huang, Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, China
Giseli Klassen, Federal University of Parana, Curitiba, Brazil
Chuan-Yuan Li, Duke University Medical Center, Durham, USA
Gang Li, University of British Columbia, Vancouver, Canada
Kiven E. Lukong, University of Saskatchewan, Saskatoon, Canada
Youyong Lu, Beijing Institute for Cancer Research, Beijing, China
Yuichi Machida, Mayo Clinic, Minnesota, USA
Kenneth Offit, Memorial Sloan-Kettering Cancer Center, New York, USA
Athanasios G. Papavassiliou, University of Athens Medical School, Athens, Greece
Kenneth Pienta, University of Michigan, An Arbor, USA
Jack A. Schalken, Radboud University Medical Centre, Nijmegen, Netherlands
Takeshi Senga, Nagoya University Graduate School of Medicine, Nagoya, Japan
Shi-Yong Sun, Emory University School of Medicine and Winship Cancer Institute, Georgia, USA
Kazu Ushijima, National Cancer Center, Tokyo, Japan
David Vaux, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
Fengyi Wan, John Hopkins University, Baltimore , USA
Meilin Wang, Nanjing Medical University, Nanjing, China
Ping Pui Wong, Barts Cancer Institute, Queen Mary University of London, London, UK
Keping Xie, The University of Texas MD Anderson Cancer Center, Houston, USA
Gong Yang, D.V.M.,Ph.D Shanghai Medical School, Fudan University, Shanghai, China
Ke-Da Yu, Fudan University Shanghai Cancer Center, Shanghai, China
Li Zhang, The University of Texas MD Anderson Cancer Center, Houston, USA
Xiang Zhou, Institutes of Biomedical Sciences and Shanghai Cancer Center, Fudan University, Shanghai, China
Clinical Cancer Research
Yung-Jue Bang, Seoul National University College of Medicine, Seoul, Korea
Anthony Chan, The Chinese University of Hong Kong, China
Ke-Neng Chen, Peking University School of Oncology, Beijing, China
Jiuwei Cui, The First Hospital of Jilin University, Jilin, China
Giuseppe Di Lorenzo, University Federico II of Napoli, Napoli, Italy
Ahmet Emre Eşkazan, Istanbul University, Istanbul, Turkey
Peter J. Fuller, Prince Henry Institute, Victoria, Australia
Maura L. Gillison, Ohio State University Comprehensive Cancer Center, Columbus, USA
Hao Guo, Dana Farber Cancer Institute, Boston, USA
Dong Hua, Affiliated Hospital of Jiangnan University, Wuxi, China
Yeul Hong Kim, Korea University College of Medicine, Seoul, Korea
Guido Kroemer, University of Paris Descartes, Paris, France
Lalit Kumar, All India Institute of Medical Sciences, New Delhi, India
Razelle Kurzrock, UCSD Moores Cancer Center, San Diego, USA
Hongyu Li, Department of Gastroenterology of Shenyang Northern Hospital, Shenyang, China
Geoffrey Liu, Princess Margaret Hospital, Toronto, Canada
Xiaowen Liu, Fudan University Shanghai Cancer Center, Fudan, China
Jiade J. Lu, Shanghai Proton and Heavy Ion Center, Shanghai, China
Li Mao, University of Maryland, Baltimore, USA
Akira Nakagawara, Chiba University, Chiba, Japan
Jingxuan Pan,Sun Yat-sen University Zhongshan Ophthalmic Center, Guangzhou, China
Pamela L. Paris, University of California, San Francisco, USA
Chao-Nan (Miles) Qian, Sun Yat-sen University Cancer Center, Guangzhou, China
Dimitrios H. Roukos, Ioannina University School of Medicine, Ioannina, Greece
Ajay Singh, University of South Alabama, Mitchell Cancer Institute, Alabama, USA
Pankaj K. Singh, University of Nebraska Medical Center, Omaha, USA
Frank A. Sinicrope, Mayo clinic, Rochester, USA
Benjamin D. Smith, The University of Texas MD Anderson Cancer Center, Houston, USA
Jun Wang, BGI-Shenzhen, Shenzhen, China
Senming Wang, Southern Medical University, Guangzhou, China
Glen J. Weiss, Translational Genomics Research Institute, Phoenix, USA
Xiaohua Wu, Fudan University Shanghai Cancer Center, Shanghai, China
Li Yan, GlaxoSmithKline Pharmaceuticals, Pennsylvania, USA
Xianglin Yuan, Huazhong University of Science and Technology, Wuhan, China
Rongyu Zang, Fudan University Zhongshan Hospital, Shanghai, China
Sheng Luo, Duke University Medical Center, Durham, NC, USA
Dinggang Li, LUDAOPEI Hematology Hospital, Beijing, China
Ninghan Feng, The Affiliated Wuxi No.2 People’s Hospital of Nanjing Medical University, Wuxi, China
Cancer Prevention
Nadine Barrett, Duke University School of Medicine, Durham, North Carolina, USA
Marianne Berwick, University of New Mexico, Albuquerque, USA
Paolo Boffetta, The Tisch Cancer Institute, New York, USA
Eduardo Cazap, Latin-American & Caribbean Society of Medical Oncology, Buenos Aires, Argentina
Kexin Chen, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
Steve Dubinett, David Geffen School of Medicine at UCLA, Los Angeles, USA
Kari Hemminki, German Cancer Research Center, Heidelberg, Germany
Zhibin Hu, Nanjing Medical University, Nanjing, China
Stephen D. Hursting, University of North Carolina, Chapel Hill, USA
Wei-Hua Jia, Sun Yat-Sen University Cancer Center, Guangzhou, China
Daehee Kang, Seoul National University College of Medicine, Seoul, Republic of Korea
Lambertus A. Kiemeney, Radboud University Medical Centre, Nijmegen, Netherlands
Qing Lan, National Cancer Institute, Maryland, USA
Donghui Li, The University of Texas MD Anderson Cancer Center, Houston, USA
Guojun Li, The University of Texas MD Anderson Cancer Center, Houston, USA
Jiachun Lu, Guangzhou Medical University, Guangdong, China
Hung N. Luu, University of South Florida, Tampa, FL and Vanderbilt University School of Medicine, Nashville, TN
Hongxia Ma, Nanjing Medical University School of Public Health, Nanjing, China
Somdat Mahabir, National Cancer Institute, Bethesda, USA
Girish Maru, ACTREC Tata Memorial Centre, Navi Mumbai, India
Xiaoping Miao, Huazhong University of Science and Technology, Wuhan, China
Andrew Olshan, University of North Carolina, Chapel Hill, USA
Jong Y. Park, H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA
Susan K. Peterson, The University of Texas MD Anderson Cancer Center, Houston, USA
Thomas E. Rohan, Albert Einstein College of Medicine, Bronx, USA
Michael E. Scheurer, Baylor College of Medicine, Houston, USA
Sheng Wei, Huazhong University of Science and Technology, Wuhan, China
Momiao Xiong, The University of Texas Health Science Center, Houston, USA
Jianfeng Xu, Northshore University HealthSystem, Evanston, USA
Xue Qin Yu, Cancer Council NSW & The University of Sydney’s School of Medicine, Sydney, Australia
Hongping Yu, Guangxi Medical University Cancer Hospital/ Guangxi Cancer Center, Guangxi, China
ZiYuan Zhou, Third Military Medical University, College of Public Health, ChongQing, China
 
Editorial Advisory Board
Lawrence Baker, University of Michigan, Ann Arbor, USA
Webster K. Cavenee, Ludwig Institute for Cancer Research, USA
David Christiani, Harvard School of Public Health, Boston, USA
Robert B. Diasio, Mayo Clinic, Rochester, USA
B. Mark Evers, Lucille P. Markey Cancer Center, Lexington, USA
Waun Ki Hong, The University of Texas MD Anderson Cancer Center, Houston, USA
Ernest Hawk, The University of Texas MD Anderson Cancer Center, Houston, USA
Leroy Hood, Institute for Systems Biology, Seattle, USA
Scott M. Lippman, University of California, San Diego, USA
Dongxin Lin, Chinese Academy of Medical Sciences, Beijing, China
James Mulé, H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA
Philip Agop Philip, Wayne State University, Detroit, USA
Steven R. Patierno, Duke University Medical Center, Durham, USA
Hongbing Shen, Nanjing Medical University, Nanjing, China
Nicholas Vogelzang, Comprehensive Cancer Centers of Nevada, Vegas, USA
Cun-Yu Wang, UCLA School of Dentistry, Los Angeles, USA
Hongyang Wang, Eastern Hepatobiliary Surgery Institute / Hospital, Shanghai, China